Literature DB >> 26960831

A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.

Juan J Muñoz1,2, Sandra A Drigo3, Hellen Kuasne1,4, Rolando A R Villacis1, Fabio A Marchi1, Maria A C Domingues5, Ademar Lopes6, Tiago G Santos1, Silvia R Rogatto7,8.   

Abstract

This study aimed to establish and characterize primary cell cultures and xenografts derived from penile carcinoma (PeCa) in order to provide experimental models for cellular processes and efficacy of new treatments. A verrucous squamous cell carcinoma (VSCC) was macrodissected, dissociated, and cultivated in KSFM/DF12 medium. Cell cultures were evaluated at passage 5 (P5) using migration and invasion assays and were serially propagated, in vivo, in BALB/c nude mice until passage 3 (X1-X3). Immunophenotypic characterization of cultures and xenografts was performed. Genomic (CytoScan HD, Affymetrix) and transcriptomic profiles (HTA 2.0 platform, Affymetrix) for VSCC, cell cultures, and xenografts were assessed. P5 cells were able to migrate, invade the Matrigel, and produce tumors in immunodeficient mice, demonstrating their malignant potential. The xenografts unexpectedly presented a sarcomatoid-like carcinoma phenotype. Genomic analysis revealed a high similarity between the VSCC and tumor-derived xenograft, confirming its xenograft origin. Interestingly, a subpopulation of P5 cells presented stem cell-related markers (CD44(+)CD24(-) and ALDH1(high)) and sphere-forming capacity, suggesting their potential xenograft origin. Cell cultures and xenografts retained the genomic alterations present in the parental tumor. Compared to VSCC, differentially expressed transcripts detected in all experimental conditions were associated with cellular morphology, movement, and metabolism and organization pathways. Malignant cell cultures and xenografts derived from a verrucous penile carcinoma were established and fully characterized. Nevertheless, xenograft PeCa models must be used with caution, taking into consideration the selection of specific cell populations and anatomical sites for cell/tumor implantation.

Entities:  

Keywords:  Experimental disease models; Mice; Neoplasms; Penile neoplasm; Primary cell cultures

Mesh:

Year:  2016        PMID: 26960831     DOI: 10.1007/s13277-016-4951-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Penile tumours: a review.

Authors:  U Wollina; F Steinbach; S Verma; G Tchernev
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-31       Impact factor: 6.166

2.  Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis.

Authors:  Bianca C Dobner; Aline I Riechardt; Antonia M Joussen; Stefan Englert; Nikolaos E Bechrakis
Journal:  Acta Ophthalmol       Date:  2012-11-20       Impact factor: 3.761

3.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

Authors:  Michael Quante; Shui Ping Tu; Hiroyuki Tomita; Tamas Gonda; Sophie S W Wang; Shigeo Takashi; Gwang Ho Baik; Wataru Shibata; Bethany Diprete; Kelly S Betz; Richard Friedman; Andrea Varro; Benjamin Tycko; Timothy C Wang
Journal:  Cancer Cell       Date:  2011-02-15       Impact factor: 31.743

4.  Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

Authors:  Raafat A El-Awady; Fatema Hersi; Hala Al-Tunaiji; Ekram M Saleh; Abdel-Hady A Abdel-Wahab; Amer Al Homssi; Mousa Suhail; Ahmed El-Serafi; Taleb Al-Tel
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Establishment and characterization of a cell line (KU-8) from squamous cell carcinoma of the penis.

Authors:  T Tsukamoto
Journal:  Keio J Med       Date:  1989-09

6.  In vitro cultivation of human islets from expanded ductal tissue.

Authors:  S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 7.  Nrf2: bane or blessing in cancer?

Authors:  MingJun Xiang; Akhileshwar Namani; ShiJun Wu; XiaoLi Wang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-06       Impact factor: 4.553

8.  Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.

Authors:  Sandra Louzada; Filomena Adega; Raquel Chaves
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

9.  Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.

Authors:  Yukihiko Hiroshima; Yong Zhang; Nan Zhang; Ali Maawy; Sumiyuki Mii; Mako Yamamoto; Fuminari Uehara; Shinji Miwa; Shuya Yano; Takashi Murakami; Masashi Momiyama; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Michael Bouvet; Takuya Murata; Itaru Endo; Robert M Hoffman
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

10.  Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.

Authors:  Hellen Kuasne; Ilce Mara de Syllos Cólus; Ariane Fidelis Busso; Hector Hernandez-Vargas; Mateus Camargo Barros-Filho; Fabio Albuquerque Marchi; Cristovam Scapulatempo-Neto; Eliney Ferreira Faria; Ademar Lopes; Gustavo Cardoso Guimarães; Zdenko Herceg; Silvia Regina Rogatto
Journal:  Clin Epigenetics       Date:  2015-04-18       Impact factor: 6.551

View more
  8 in total

1.  Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor.

Authors:  Hellen Kuasne; Mateus C Barros-Filho; Fábio A Marchi; Sandra A Drigo; Cristovam Scapulatempo-Neto; Eliney F Faria; Silvia R Rogatto
Journal:  Virchows Arch       Date:  2018-08-11       Impact factor: 4.064

Review 2.  Immune-based therapies in penile cancer.

Authors:  Vidhu B Joshi; Philippe E Spiess; Andrea Necchi; Curtis A Pettaway; Jad Chahoud
Journal:  Nat Rev Urol       Date:  2022-07-18       Impact factor: 16.430

3.  Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro.

Authors:  Patrícia F Lainetti; Antonio F Leis-Filho; Priscila E Kobayashi; Laíza S de Camargo; Renee Laufer-Amorim; Carlos E Fonseca-Alves; Fabiana F Souza
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

4.  Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.

Authors:  Jieping Chen; Kai Yao; Zaishang Li; Chuangzhong Deng; Liangjiao Wang; Xingsu Yu; Peili Liang; Qiankun Xie; Peng Chen; Zike Qin; Yunlin Ye; Zhuowei Liu; Fangjian Zhou; Zhenfeng Zhang; Hui Han
Journal:  Oncotarget       Date:  2016-08-09

5.  Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.

Authors:  Qiang-Hua Zhou; Chuang-Zhong Deng; Zai-Shang Li; Jie-Ping Chen; Kai Yao; Kang-Bo Huang; Ting-Yu Liu; Zhuo-Wei Liu; Zi-Ke Qin; Fang-Jian Zhou; Wenlin Huang; Hui Han; Ran-Yi Liu
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

6.  Effective combinatorial immunotherapy for penile squamous cell carcinoma.

Authors:  Tianhe Huang; Xi Cheng; Jad Chahoud; Ahmed Sarhan; Pheroze Tamboli; Priya Rao; Ming Guo; Ganiraju Manyam; Li Zhang; Yu Xiang; Leng Han; Xiaoying Shang; Pingna Deng; Yanting Luo; Xuemin Lu; Shan Feng; Magaly Martinez Ferrer; Y Alan Wang; Ronald A DePinho; Curtis A Pettaway; Xin Lu
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

Review 7.  Systemic treatment of penile squamous cell carcinoma-hurdles and hopes of preclinical models and clinical regimens: a narrative review.

Authors:  Silvia Regina Rogatto; Igor Tsaur; Anita Thomas; Luisa Matos do Canto Alvim; Claudia Aparecida Rainho; Eva Juengel; Roman Alexander Blaheta; Philippe E Spiess
Journal:  Transl Androl Urol       Date:  2021-10

8.  Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo.

Authors:  Patrícia de Faria Lainetti; Andressa Brandi; Antonio Fernando Leis Filho; Maria Carolina Mangini Prado; Priscila Emiko Kobayashi; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Front Vet Sci       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.